Janet +61 411 816 444
PO Box 636 Bondi Junction NSW 1355
Australia
The LAM Australasia Research Alliance (LARA) is dedicated to improving the health prospects of women with LAM in Australia, New Zealand and throughout the region. A disease that affects only women, LAM is rare and often devastating.
ALL DONATIONS TO LARA ARE FULLY TAX DEDUCTIBLE
Your contribution to LARA will go 100% to funding vital medical research to find a cure for LAM.
You can donate to the LAM Australasia Research Alliance by sending us a cheque, using our PayPal facility, or by making a deposit directly to our ANZ Bank account: 012 055 4926 67193.
Please advise us of your donation by sending an email to admin@lara.org.au with your name, address and email address. We will respond with our thanks and a fully tax deductible receipt.
Major Donors
Macquarie Group Foundation
Roth Charitable Foundation
Mr Robert Gavshon
Hollick Wines
Acknowledgements
LARA thanks the professionals who work pro bono for this not-for-profit organisation. We highly recommend the services of:
Ben Higham, Webhead
Karen Riethmuller, KGR Design
Peter Hersh, Loggica Pty Ltd
Peter Kelso
|
LARA LAM Symposium 2008
|
|
Helping to determine LARA's forthcoming research projects, members of LARA's Medical and Scientific Advisory Board, Prof Judith Black AO and Prof David Sonnabend of the University of Sydney, met with Dr Jeff Lindenmayer of Melbourne at LARA's first LAM Symposium held at the University of Sydney on 10 November 2008. Prof Allan Glanville of St Vincent's Hospital Sydney and Prof Greg Snell of The Alfred Hospital Melbourne joined the meeting by telephone. Members of the LARA Executive were present but did not participate in the discussions. The meeting was adddressed by telephone by representatives of the US-based National Disease Research Interchange (NDRI) www.ndriresource.org which collects organs, blood, serum, chyle and asites from women with LAM and others in USA and Europe, rushing the samples to researchers. The meeting discussed whether NDRI could extend its activites to Australia, facilitating access to LAM tissue, explanted lungs etc for research. NDRI is interested, but needs to familiarise itself with this region, its major hospitals, research labs, protocols customs regulations, and other issues. Melbourne representatives of Circadian Technolgies www.circadian.com.au were linked by phone to the meeting, listening to NDRI's presentation. Circadian may be able to help research efforts.Prof Allan Glanville spoke of ShareLife Australia www.sharelifeaustralia.com.au a business-led organisation focused on improving the availability of organs for transplantation. Ian Eslick of LAMsight www.lamsight.org based at MIT Media Lab, Boston USA addressed the meeting in person, explaining his work with Amy Farber of the LAM Treatment Alliance www.lta.org to create a centralised database of LAM patients, thier symptoms and treatments. To be accessible to women with LAM, their families, clinicians and researchers, the site will provide an invaluable resource for cross-checking data and formalting research proposals. Dr Lyn Moir, inaugural recipient of the LARA & NZ LAM Trust Scholarship, talked about her ongoing research. She and the head of the University of Sydney LAM research, Prof Judy Black, stressed the importance of acquiring LAM tissue for research. |